Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. News
  3. medical infection
Show results for
Products
Services
Software
Training
Applications

Companies

News
Articles
Downloads
Videos

Refine by
Date

  • Older

Medical Infection Articles & Analysis

85 news found

CDC Report: Burkholderia multivorans Infections Linked to Hospital Ice Machines

CDC Report: Burkholderia multivorans Infections Linked to Hospital Ice Machines

A Centers for Disease Control and Prevention (CDC) report published on October 3, 2024, linked Burkholderia multivorans infections to ice machines in multiple healthcare facilities in the western United States. This post summarizes key findings, implications, and recommended practices for healthcare providers to ensure patient ...

ByLiquitech, Inc.


Vancomycin-Resistant Enterococci (VRE) in Healthcare Settings Discussed in New Online Video

Vancomycin-Resistant Enterococci (VRE) in Healthcare Settings Discussed in New Online Video

The IAQ Video Network and Cochrane & Associates announced the release of their latest educational video today. Their newest production discusses vancomycin-resistant enterococci, commonly referred to as VRE, which are bacteria that can cause various healthcare-associated infections (HAIs). “In the CDC’s 2019 Antibiotic Resistance Threats in the United States report, VRE was ...

ByCochrane & Associates, LLC


Aspergillus Infection Risks in Hospitals, Homes and Buildings

Aspergillus Infection Risks in Hospitals, Homes and Buildings

Aspergillosis is a potentially life-threatening condition caused by a fungal pathogen known as Aspergillus. It is a common type of mold found outdoors and in indoor environments. It can be found at excessive concentrations indoors when buildings suffer water damage or elevated humidity levels. Fortunately, most healthy people breathe Aspergillus spores without infection concerns. However, some ...

ByCochrane & Associates, LLC


Infection Control Resources to Safeguard Patients and Building Occupants from Acinetobacter and Other Pathogens

Infection Control Resources to Safeguard Patients and Building Occupants from Acinetobacter and Other Pathogens

The Centers for Disease Control and Prevention describe Acinetobacter as a group of bacteria commonly found in the environment in places like soil and water. While there are many types, the most frequent cause of infections in humans is known as Acinetobacter baumannii. Those most at risk of infection according to the CDC include patients in hospitals, especially those who: · are ...

ByCochrane & Associates, LLC


Infection Control Resources in Puerto Rico to Identify Acinetobacter and Other Microbial Pathogens

Infection Control Resources in Puerto Rico to Identify Acinetobacter and Other Microbial Pathogens

Acinetobacter is described by the Centers for Disease Control and Prevention (CDC) as a group of bacteria commonly found in the environment in places like soil and water. While there are many types, the most frequent cause of infections in humans is known as Acinetobacter baumannii. Infections of the blood, urinary tract and lungs, or in wounds in other parts of the body can all be caused by ...

ByCochrane & Associates, LLC


Mitigating Aspergillus Infection Risks in Hospitals and Buildings across Puerto Rico

Mitigating Aspergillus Infection Risks in Hospitals and Buildings across Puerto Rico

A potentially life-threatening condition known as aspergillosis is caused by a fungal pathogen named Aspergillus. It is a common type mold that can often be found outdoors and in indoor environments that have suffered water damage or elevated humidity levels. Fortunately, most healthy people breathe Aspergillus spores without infection concerns. However, some species are known to be a serious ...

ByCochrane & Associates, LLC


7 December 2022 - FDA/CDC highlight need for infection preventions

7 December 2022 - FDA/CDC highlight need for infection preventions

Particular support for decolonisation of pathogens which is the approach taken by its XF-73 Nasal programme Destiny Pharma plc (AIM: DEST), a clinical stage innovative biotechnology company focused on the development of novel medicines that can prevent life-threatening infections, today reports on the publication of findings from the US Food and Drug Administration (FDA) and US Centers for ...

ByDestiny Pharma plc


XF-73 Nasal Phase 3 development plans finalised

XF-73 Nasal Phase 3 development plans finalised

A single MRSA post-surgical infection costs over $160,000 to treat and adds 15 days onto a hospital stay. ...

ByDestiny Pharma plc


Candida auris and Infection Control Resources for Healthcare Facilities in Puerto Rico

Candida auris and Infection Control Resources for Healthcare Facilities in Puerto Rico

Several years ago, the Centers for Disease Control and Prevention (CDC) announced it was establishing the Antibiotic Resistance Laboratory Network (AR Lab Network) in Puerto Rico and all 50 states. It was designed to help detect new forms of drug resistance as novel fungal threats emerge. Specifically mentioned in the announcement was Candida auris. CDC reported that this fungus poses a unique ...

ByCochrane & Associates, LLC


Successful SARS-CoV-2 trial with Ondine’s nasal photodisinfection

Successful SARS-CoV-2 trial with Ondine’s nasal photodisinfection

Clínica Universidad de Navarra has completed a randomised controlled study of Ondine Biomedical’s nasal photodisinfection technology in fully vaccinated COVID-19 patients with early symptoms of COVID-19. “Top-line results from this clinical trial suggest that nasal photodisinfection treatment rapidly and substantially suppresses SARS-CoV-2 viral replication and infectivity in ...

ByOndine Biomedical Inc


HiberGene Diagnostics introduces brand new UK division at NEQAS event

HiberGene Diagnostics introduces brand new UK division at NEQAS event

HiberGene Diagnostics, the leading manufacturer of molecular diagnostics products in Ireland, is pleased to announce that it will supply its innovative point-of-care (POC) and near-patient testing solutions directly to healthcare providers in the UK and Ireland. These high-quality testing solutions cover infectious and transmissible disease areas – including respiratory, sexually ...

ByHiberGene Diagnostics


WHO calls for new innovations to tackle antimicrobial resistance crisis

WHO calls for new innovations to tackle antimicrobial resistance crisis

Antimicrobial resistance (AMR) threatens the effective prevention and treatment of an ever-increasing range of infections caused by bacteria, parasites, viruses and fungi Ondine’s nonantibiotic photodisinfection technology has been proven in Canadian hospitals to kill pathogens helping to generate 84% reduction of postoperative infection rates and significant cost savings. The World ...

ByOndine Biomedical Inc


N8 Medical Announces First-in-Human Use of its CeraShield™ Endotracheal Tube

N8 Medical Announces First-in-Human Use of its CeraShield™ Endotracheal Tube

N8 Medical, LLC (N8 Medical) today announced its first-in-human clinical trials of its flagship CeraShield™ endotracheal tube (CeraShield™ ETT) for intensive care unit patients expected to require mechanical ventilation for more than 48 hours. ...

ByN8 Medical, LLC


Rocket Pharmaceuticals Presents Positive Top-line Data from Severe Leukocyte Adhesion Deficiency-I Program at the 25th Annual Meeting of the American Society of Gene and Cell Therapy (ASGCT)

Rocket Pharmaceuticals Presents Positive Top-line Data from Severe Leukocyte Adhesion Deficiency-I Program at the 25th Annual Meeting of the American Society of Gene and Cell Therapy (ASGCT)

CD18 is a key protein that facilitates leukocyte adhesion and extravasation from blood vessels to combat infections. As a result, children with severe LAD-I are often affected immediately after birth. During infancy, they suffer from recurrent life-threatening bacterial and fungal infections that respond poorly to antibiotics and require frequent ...

ByRocket Pharmaceuticals, Inc.


TriMedika Wins Innovate UK Women in Innovation Awards

TriMedika Wins Innovate UK Women in Innovation Awards

Roisin Molloy, CEO, and co-founder of TriMedika; an innovative medical technology manufacturer, supplying the most accurate hospital-grade non-contact thermometers to hospitals worldwide, based in Belfast. ...

ByTriMedika


CloudCath Announces $12 Million Series A Financing for Technology Enabling Remote, Real-Time Complication Monitoring for At-Home Dialysis

CloudCath Announces $12 Million Series A Financing for Technology Enabling Remote, Real-Time Complication Monitoring for At-Home Dialysis

For patients undergoing peritoneal dialysis (PD), rates of infection-driven hospitalization are as high as 0.5 hospitalizations per patient year, according to the U.S. ...

ByCloudCath


UVD Robots Joins Ecolab to Fight Hospital Acquired Infections

UVD Robots Joins Ecolab to Fight Hospital Acquired Infections

As new coronavirus variants continue to mutate and spread, the growth in demand for infection prevention solutions using UV-C light is projected to reach $18.94 billion by 2030, witnessing an annual growth rate of 59.7% from 2021 to 2030. Further fueling the demand is the rise in hospital acquired infections (HAIs) that globally cause more fatalities due to the increase in antibiotic resistance ...

ByBlue Ocean Robotics


UVD Robots Joins Ecolab to Fight Hospital Acquired Infections

UVD Robots Joins Ecolab to Fight Hospital Acquired Infections

As new coronavirus variants continue to mutate and spread, the growth in demand for infection prevention solutions using UV-C light is projected to reach $18.94 billion by 2030, witnessing an annual growth rate of 59.7% from 2021 to 2030. Further fueling the demand is the rise in hospital acquired infections (HAIs) that globally cause more fatalities due to the increase in antibiotic resistance ...

ByUVD Robots, PART OF BLUE OCEAN ROBOTICS


Members of Congress Urge CMS to Take Action to Reduce Preventable False-Positive Diagnostic Test Results for Sepsis

Members of Congress Urge CMS to Take Action to Reduce Preventable False-Positive Diagnostic Test Results for Sepsis

Magnolia Medical Technologies, Inc., inventors of Steripath®, the only FDA 510(k)-cleared device platform indicated to reduce blood culture contamination for sepsis testing1, commended U.S. ...

ByMagnolia Medical Technologies


Clinical Data of The Visby Medical Sexual Health Click Test Published in Journal of the American Sexually Transmitted Diseases Association

Clinical Data of The Visby Medical Sexual Health Click Test Published in Journal of the American Sexually Transmitted Diseases Association

Visby Medical™, a leading medical diagnostic company, today announced results from the cross-sectional single visit patient outcomes and implementation study, which evaluated self-collected vaginal swab samples from 55 women using the Visby Medical Sexual Health Click Test for Chlamydia trachomatis (CT), Neisseria gonorrhoeae (NG), and ...

ByVisby Medical, Inc.

  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical XPRT Industry Products
  • Medical XPRT Industry Software
  • Medical XPRT Industry Training
  • Medical XPRT Industry Services
  • Medical XPRT Industry Applications

Latest

  • Medical XPRT Industry News
  • Medical XPRT Industry Events

Publications

  • Medical XPRT Industry Articles
  • Medical XPRT Industry Books
  • Medical XPRT Industry Magazines
  • Medical XPRT Industry Downloads
  • Medical XPRT Industry Videos

Companies

  • Medical XPRT Industry Companies

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT